A Guide to the Clinical Care of Women with HIVJean R. Anderson DIANE Publishing Inc., 2005 - 612 pages NOTE: NO FURTHER DISCOUNT FOR THIS PRODUCT ITEM -OVERSRTOCK SALE-- Significantly reduced price. Edited by Jean R. Anderson. This guide addresses the health care needs unique to women with HIV. It targets clinicians who provide primary care to women as well as those seeking an understanding of how to take care of women with HIV/AIDS. This guide includes tables, figures, color plates, resources, references, and indices. This 2005 edition includes new chapters on international issues and nutrition. Edge indexed." |
From inside the book
Results 1-5 of 63
Page 82
... nevirapine or tenofovir , be tested as an HIV prevention strategy for individuals at particularly high risk ( e.g. , commercial sex workers in high HIV prevalence settings ) ( Youle , 2003 ) . Individual providers who are approached by ...
... nevirapine or tenofovir , be tested as an HIV prevention strategy for individuals at particularly high risk ( e.g. , commercial sex workers in high HIV prevalence settings ) ( Youle , 2003 ) . Individual providers who are approached by ...
Page 112
... nevirapine , delavirdine , and efavirenz ( Table 4-5 ) . Primary Medical Care Generic Name Table 4-5 : Nonnucleoside Reverse 112 US . Department of Health and Human Services , Health Resources and Services Administration , HIV / AIDS ...
... nevirapine , delavirdine , and efavirenz ( Table 4-5 ) . Primary Medical Care Generic Name Table 4-5 : Nonnucleoside Reverse 112 US . Department of Health and Human Services , Health Resources and Services Administration , HIV / AIDS ...
Page 113
... Nevirapine Viramune 200 mg qd x 14 Rash , hepatitis days , then 200 mg bid ( 2 pills / day ) Delavirdine Rescriptor 400 mg tid Rash ( 12 pills / day ) Efavirenz Sustiva 600 mg qd Headache , ( qhs dizziness , administration may limit CNS ...
... Nevirapine Viramune 200 mg qd x 14 Rash , hepatitis days , then 200 mg bid ( 2 pills / day ) Delavirdine Rescriptor 400 mg tid Rash ( 12 pills / day ) Efavirenz Sustiva 600 mg qd Headache , ( qhs dizziness , administration may limit CNS ...
Page 115
... Nevirapine has the greatest potential for causing hepatotoxicity ( up to 12 % ) and this complication appears to be more common in women ( Martinez , 2001 ; Bartlett , 2003 ) . Nevirapine - associated hepatitis might also be part of a ...
... Nevirapine has the greatest potential for causing hepatotoxicity ( up to 12 % ) and this complication appears to be more common in women ( Martinez , 2001 ; Bartlett , 2003 ) . Nevirapine - associated hepatitis might also be part of a ...
Page 116
... Nevirapine should not be used in future regimens in women who experience severe liver toxicity while taking nevirapine . Pl - associated hepatotoxicity can occur any time during the treatment course . Risk factors for liver toxicity ...
... Nevirapine should not be used in future regimens in women who experience severe liver toxicity while taking nevirapine . Pl - associated hepatotoxicity can occur any time during the treatment course . Risk factors for liver toxicity ...
Other editions - View all
Common terms and phrases
abacavir abnormal adherence adolescents AIDS alcohol Amprenavir antiretroviral drugs antiretroviral therapy assessment associated AUC increased behavior candidiasis CD4 cell counts CD4 count chronic Clin condom contraception counseling culture decreased Delavirdine diagnosis didanosine dose Efavirenz evaluation exposure fetal HAART hepatic hepatic metabolism HIV and Reproduction HIV disease HIV infection HIV RNA HIV transmission HIV-Infected Pregnant Patients HIV-infected women HIV-positive women HIV/AIDS human immunodeficiency virus Immediate Major Immediate Moderate increased risk Indinavir Induction of hepatic infants Inhibition of hepatic interaction intervention lamivudine lesions maternal mg bid mg qd Monitor Nelfinavir nevirapine Nutrition oral pain Pap smear perinatal transmission Pharmacologic Considerations potential pregnancy pregnant women Primary Medical prophylaxis providers psychiatric recommended regimen resistance rifabutin ritonavir Saquinavir stavudine studies substance abuse symptoms Table tenofovir teratogenic toxicity treatment vaccine vaginal viral load women with HIV zidovudine
References to this book
The Experiences of Women with AIDS Who Have Received Occupational Therapy in ... Ruth A. M. Meyers No preview available - 2006 |